{
    "clinical_study": {
        "@rank": "64015", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I. Determine the frequency and severity of osteopenia and osteoporosis in patients with\n      thalassemia major who undergo dual energy x-ray absorptiometry, and correlate these findings\n      with other relevant endocrinologic measurements."
        }, 
        "brief_title": "Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major", 
        "completion_date": "August 2000", 
        "condition": [
            "Osteoporosis", 
            "Thalassemia Major", 
            "Osteopenia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Beta-Thalassemia", 
                "Bone Diseases, Metabolic", 
                "Osteoporosis", 
                "Thalassemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients undergo dual energy x-ray absorptiometry for bone density measurements, height\n      (sitting and standing) and weight measurements, comprehensive endocrinologic examination,\n      and assessment of the severity of iron overload at baseline, and then at years 1 and 2."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Diagnosis of thalassemia major with iron overload\n\n          -  Not pregnant\n\n          -  Negative pregnancy test"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": "35", 
        "firstreceived_date": "August 3, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00006138", 
            "org_study_id": "199/15314", 
            "secondary_id": [
                "CHP-IRB-1998-6-1502", 
                "CHP-GCRC-1655"
            ]
        }, 
        "keyword": [
            "disease-related problem/condition", 
            "genetic diseases and dysmorphic syndromes", 
            "hematologic disorders", 
            "osteoporosis", 
            "rare disease", 
            "thalassemia major"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Children's Hospital of Philadelphia", 
            "last_name": "Alan Richard Cohen", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00006138"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Hospital of Philadelphia", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1998", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "October 2000"
    }, 
    "geocoordinates": {}
}